반응식
[CH:1]1([C:6](Cl)=[O:7])[CH2:5][CH2:4][CH2:3][CH2:2]1.[O:9]=[C:10]1[NH:16][C:15]2[CH:17]=[C:18]([CH3:21])[CH:19]=[CH:20][C:14]=2[NH:13][CH2:12][CH:11]1[NH:22][C:23]([O:25][C:26]([CH3:29])([CH3:28])[CH3:27])=[O:24].O=C1NC2C=CC=CC=2NCC1NC(OC(C)(C)C)=O>>[O:9]=[C:10]1[NH:16][C:15]2[CH:17]=[C:18]([CH3:21])[CH:19]=[CH:20][C:14]=2[N:13]([C:6]([CH:1]2[CH2:5][CH2:4][CH2:3][CH2:2]2)=[O:7])[CH2:12][CH:11]1[NH:22][C:23]([O:25][C:26]([CH3:29])([CH3:28])[CH3:27])=[O:24]참가 물질
4
실험 절차
Step 1 of Example 1 was repeated except that cyclopentylcarbonyl chloride was used instead of pivaloyl chloride, and that 2-oxo-3-tert-butoxycarbonylamino-8-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine obtained from Referential Example 4 was used instead of 2-oxo-3-tert-butoxycarbonylamino-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine, to thereby obtain the title compound.
출처 및 근거
- ORD 기록
- ord-2e9220b093cb4c93864b1382bb275986
- 출처 데이터셋
- uspto-grants-2001_05
- 특허 번호
- US06239131B1
연결된 노트
불러오는 중…